Matthew J. Fivash

National Cancer Institute

Papers

1

Total Citations

11

H-Index

1

About

Matthew J. Fivash is a proteomics researcher whose work focuses on applying advanced mass spectrometry techniques to improve cancer diagnostics, particularly in lung cancer. His key research areas include matrix-assisted laser desorption/ionization (MALDI) mass spectrometry, biomarker discovery, and the proteomic analysis of clinical tissue samples. Fivash’s major contribution lies in demonstrating that proteomic signatures can be obtained from small, bronchoscopic biopsy samples—rather than larger surgical specimens—potentially enabling earlier and less invasive cancer diagnosis. His most cited paper, “Matrix‐assisted laser desorption/ionization mass spectrometry reveals decreased calcylcin expression in small cell lung cancer” (2011, 11 citations), highlights a specific protein expression change that could serve as a diagnostic marker. This work is notable for shifting the focus toward minimally invasive sampling methods, which could accelerate diagnosis and treatment decisions. Fivash’s research underscores the promise of proteomics in clinical oncology, offering a pathway to more timely and precise cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Matrix‐assisted laser desorption/ionization mass spectrometry reveals decreased calcylcin expression in small cell lung cancer
11 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: National Cancer Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago